meropenem + imipenem + caspofene + Osstat

This is a combination product purportedly containing four agents: meropenem, imipenem, caspofene, and Osstat. Meropenem and imipenem are both carbapenem antibiotics with broad-spectrum activity against Gram-positive and Gram-negative bacteria. They act by binding to penicillin-binding proteins (PBPs) and inhibiting bacterial cell wall synthesis, leading to cell death[1][3][4][5][7]. Both are used for severe or high-risk bacterial infections including complicated intra-abdominal infections, pneumonia (including hospital-acquired), septicemia, skin structure infections, urinary tract infections, and others[2][3][5][7]. Caspofene does not correspond to any known approved drug or antibiotic; it may be a misspelling or an unrecognized compound. Similarly, "Osstat" does not match any recognized pharmaceutical agent in current medical databases or literature. Therefore, the full mechanism of action for this combination cannot be determined due to the lack of information on two components.

Other names

meropenem + imipenem + caspofene + Osstat